AHL Partners’s Biogen BIIB Stock Holding History

AHL Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$5.32M	Sell	16,695 -5,065	-23%	-$1.62M	0.08%	464
2017 Q3	$6.81M	Buy	21,760 +4,113	+23%	+$1.22M	0.12%	303
2017 Q2	$4.79M	Buy	17,647 +9,511	+117%	+$2.51M	0.1%	363
2017 Q1	$2.22M	Buy	8,136 +5,612	+222%	+$1.59M	0.05%	606
2016 Q4	$716K	Buy	2,524 +1,069	+73%	+$317K	0.02%	731
2016 Q3	$455K	Sell	1,455 -210	-13%	-$62.2K	0.02%	865
2016 Q2	$402K	Buy	+1,665	New	+$439K	0.02%	649
2016 Q1	–	Sell	-7,803	Closed	-$2.39M	–	757
2015 Q4	$2.39M	Buy	7,803 +6,917	+781%	+$1.99M	0.19%	202
2015 Q3	$259K	Sell	886 -10,911	-92%	-$3.6M	0.04%	603
2015 Q2	$4.77M	Sell	11,797 -382	-3%	-$153K	0.19%	202
2015 Q1	$5.14M	Buy	12,179 +4,843	+66%	+$1.91M	0.21%	172
2014 Q4	$2.49M	Buy	+7,336	New	+$2.37M	0.13%	351

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

AHL Partners's BIIB Position: Q4 2017 in Review

AHL Partners reduced its Biogen (BIIB) stake by 23% in Q4 2017, selling an estimated $1.62M and leaving 16,695 shares worth $5.32M. The position accounts for 0.08% of the portfolio, ranked #464.

AHL Partners first reported a position in BIIB in Q4 2014 and has held it in 12 quarters since. The position peaked at $6.81M in Q3 2017. 1,123 funds tracked by Wall St. Rank hold BIIB as of Q4 2017.

AHL Partners held 16,695 shares of Biogen worth $5.32M as of Q4 2017.
AHL Partners sold 5,065 Biogen shares in Q4 2017, an estimated $1.62M.
Biogen made up 0.08% of AHL Partners's portfolio in Q4 2017, its #464 holding.
AHL Partners first reported a position in Biogen in Q4 2014 and has held it in 12 quarters since.
AHL Partners's Biogen position peaked at $6.81M in Q3 2017.
1,123 funds tracked by Wall St. Rank held Biogen as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.